Time spent on rituximab infusion and its impact on patient and caregiver burden


Understanding patient perspectives regarding rituximab administration is important as stakeholders make decisions between intravenous (IV) and the recently-approved subcutaneous method of administration. Most patients reported that time-reduction would have a positive impact on their life. Understanding the patient's perspective and overall time burden of rituximab administration will benefit clinical decision-making and quality of care.